Shoji M, Iwakami N, Takeuchi S, Waragai M, Suzuki M, Kanazawa I, et al
Before initiating any GLP-1 therapy, patients should discuss contraindications, medical history, and realistic expectations with their healthcare team
51 These findings raise an important question: How much LPO is needed to kill hepatocytes
Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective propertiesready for use in the stroke clinic
Meta-analysis of the symptom structure of obsessive-compulsive disorder
In patients with T2D who need their treatment regimen intensified to include injectable therapy, the guidelines now recommend considering a GLP-1 receptor agonist in most patients prior to initiating insulin therapy [20]